Showing results (11-20 of 94) with videos related to
Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trialD F Bajorin, J A McCaffrey, S Hilton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinomaJ A McCaffrey, S Hilton, M Mazumdar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tractP M Dodd, J A McCaffrey, S Hilton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinomaP M Dodd, J A McCaffrey, H Herr, et al.Seminars in Oncology|October 1, 1994
Etoposide plus carboplatin or cisplatin in good-risk patients with germ cell tumors: a randomized comparisonG J Bosl, D F BajorinCurrent Opinion in Urology|October 14, 2006
New chemotherapy regimens for metastatic bladder cancerP M Dodd, D F BajorinSeminars in Urologic Oncology|March 15, 2001
Chemotherapy agents in transitional cell carcinoma: the old and the newF C Maluf, D F BajorinCancer|March 30, 2000
Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dosing schedulesD F Bajorin, J A McCaffrey, P M Dodd, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcomeH W Herr, D F Bajorin, H I ScherThe Journal of Urology|February 15, 2001
Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancerH W Herr, S M Donat, D F BajorinPageof 10